Pathalys Pharma
Clinical trials sponsored by Pathalys Pharma, explained in plain language.
-
New hope for dialysis patients: drug targets hormone imbalance
Disease control CompletedThis study tested a new drug called PLS240 in 362 adults with end-stage kidney disease on dialysis who also have overactive parathyroid glands (secondary hyperparathyroidism). The goal was to see if PLS240 can safely lower high parathyroid hormone levels. Participants received ei…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New hope for dialysis patients: drug targets hormone imbalance
Disease control CompletedThis study tested a drug called PLS240 in 412 adults with end-stage kidney disease on dialysis who also have overactive parathyroid glands (secondary hyperparathyroidism). The goal was to see if the drug can safely lower high parathyroid hormone levels. Participants received eith…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated May 22, 2026 13:51 UTC